Efficacy and safety of a novel TKI (anlotinib) for the treatment of advanced digestive system neoplasms: a systematic review and meta-analysis
Article in Frontiers in Immunology (August 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (August 2024)
Article in Journal of Gastrointestinal Oncology (August 2024)
Preprint in Research Square (January 2024)